CTIS.eu › Cities › Netherlands › Heerlen
Heerlen
Netherlands
88 total trials
35 recruiting
2024-511409-42-00
6
2024-09-02
Actinic Keratosis
2022-501392-81-00
6
2024-07-25
Obesity
2023-508630-34-00
5
2024-05-28
Overweight
2023-504471-25-00
5
2024-03-01
Fibrotic Lung Disease
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
2022-502664-21-00
6
2023-05-01
multiple sclerosis
2023-509320-17-00
6
2023-03-28
non-radiographic axial spondyloarthritis
2022-501534-33-00
6
2023-03-06
Unexplained Subfertility, infertility
2024-511340-29-02
5
2022-12-14
Late-onset hypogonadism
2023-509429-37-00
5
2022-10-03
Advanced or Metastatic Non-Small Cell Lung Cancer
2023-504360-42-00
6
2022-05-13
Non-ST-segment elevation acute coronary syndrome
2024-510620-39-00
5
2021-04-19
Advanced RCC with clear cell component
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
2024-511334-12-00
4
2018-11-19
Smoldering Multiple Myeloma
2022-501076-26-00
4
2018-08-28
high risk diffuse large B-cell lymphoma
2024-516204-42-00
5
2017-11-21
Breast cancer
2023-507889-89-00
5
2016-02-19
Respiratory tract infection
2024-516202-39-00
4
2013-10-10
Metastatic breast cancer
2023-506185-31-00
10
2024-07-18
Idiopathic pulmonary fibrosis (IPF)
2023-504678-39-00
4
2024-03-13
Heart Failure
2023-505543-39-00
5
2024-02-12
Chronic Obstructive Pulmonary Disease (COPD)
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
Showing 49–72 of 88 trials